BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16551520)

  • 1. Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.
    Belani CP
    Lung Cancer; 2005 Dec; 50S2():S3-S8. PubMed ID: 16551520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.
    Belani CP
    Lung Cancer; 2005 Dec; 50 Suppl 2():S3-8. PubMed ID: 16557668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing first-line treatment options for patients with advanced NSCLC.
    Wakelee H; Belani CP
    Oncologist; 2005; 10 Suppl 3():1-10. PubMed ID: 16368866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing chemotherapy and targeted agent combinations in NSCLC.
    Lynch T; Kim E
    Lung Cancer; 2005 Dec; 50S2():S25-S32. PubMed ID: 16551519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for advanced stage non-small cell lung cancer.
    Fathi AT; Brahmer JR
    Semin Thorac Cardiovasc Surg; 2008; 20(3):210-6. PubMed ID: 19038730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the role of topotecan in the treatment of non-small cell lung cancer.
    Stewart DJ
    Oncologist; 2004; 9 Suppl 6():43-52. PubMed ID: 15616149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
    Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
    Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
    Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
    Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.
    Grossi F; Aita M; Defferrari C; Rosetti F; Brianti A; Fasola G; Vinante O; Pronzato P; Pappagallo G
    Oncologist; 2009 May; 14(5):497-510. PubMed ID: 19423674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line chemotherapy for advanced-stage non-small-cell lung cancer: focus on docetaxel.
    Ramalingam S
    Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S77-82. PubMed ID: 16384540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in chemotherapy for advanced non-small cell lung cancer.
    Raez LE; Lilenbaum R
    Curr Opin Oncol; 2006 Mar; 18(2):156-61. PubMed ID: 16462185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel in the treatment of advanced non-small-cell lung cancer.
    Saloustros E; Georgoulias V
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1207-22. PubMed ID: 18699760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patient management in metastatic non-small cell lung cancer.
    Vansteenkiste J
    Lung Cancer; 2007 Aug; 57 Suppl 2():S12-7. PubMed ID: 17686440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stage IV non small cell bronchial carcinoma; first line therapy in 2007].
    LemariƩ E
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S101-7. PubMed ID: 18235401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
    Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
    J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populations.
    Belani CP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S10-22. PubMed ID: 19780242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Second-line treatment and targeted therapy of advanced lung cancer].
    Nakamura Y; Yamamoto N
    Gan To Kagaku Ryoho; 2009 May; 36(5):710-6. PubMed ID: 19461168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer].
    Fournel P
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for Stage IV Non-Small Cell Lung Cancer: Protocol Versus Nonprotocol? Is Noninvestigational Treatment Worthwhile? Patient Selection? Which Regimen? What's Next?
    Bonomi P
    Semin Radiat Oncol; 1996 Apr; 6(2):110-117. PubMed ID: 10717170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.